Skip to content

Study on the effectiveness and safety of HemCon Bandage to stop bleeding at the femoral artery puncture point in patients with thrombocytopenia

Study on the effectiveness and safety of HemCon Bandage to stop bleeding at the femoral artery puncture point in patients with thrombocytopenia - Study on the effectiveness and safety of HemCon Bandage to stop bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095393
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thrombocytopenia

Interventions

experimental group:Use HemCon Bandage for compression hemostasis

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1)Patients undergoing interventional operation through femoral artery puncture; (2) Age 18-90 years old, gender unlimited; (3) Patients with thrombocytopenia, platelet count less than 100×10^9/L; (4) Expected survival >= 3 months; (5) Understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who cannot receive interventional treatment; (2) Prolonged ATPP/PT/TT, otherwise prone to delayed bleeding (3) Active severe clinical infection (> Grade 2, NCI-CTCAE version 4.0) within 14 days prior to enrollment, including active tuberculosis; (4) Known or self-reported HIV infection; (5) uncontrolled systemic diseases, such as poorly controlled diabetes; (6) known hypersensitivity or allergic reaction to any component of the investigational drug; (7) any condition that the investigator determines to be unstable or likely to compromise the subject's safety and compliance with the study; Comorbidities or social circumstances that could prevent subjects from following the study plan or even endanger patient safety.

Design outcomes

Primary

MeasureTime frame
Compression hemostatic time;No hematoma was found;

Secondary

MeasureTime frame
vascular complication;Local complication;Local ecchymosis;

Countries

China

Contacts

Public ContactChang Liu

West China Hospital of Sichuan University

westchina_lc@foxmail.com+86 189 8060 6382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026